Riskpilot← Back to searchSign inGet full accessRebalancevet ApS
APSActiveCVR 41542829Caroline Amalie Vej 137BVeterinary activities · NACE 7500Est. 20201 employees
Revenue 2024
DKK 992K
-34% vs 2023
EBITDA margin
4.8%
+147% vs 2023
Equity ratio
49.4%
Financial strength
Net profit 2024
DKK 38K
+148% vs 2023
| Revenue | DKK 992K | -34% |
| EBITDA | DKK 48K | +147% |
| Net profit | DKK 38K | +148% |
| Total assets | DKK 342K | -13% |
| Equity | DKK 169K | -12% |
| Employees | 1 | — |
Legal name
Rebalancevet ApS
CVR number
41542829
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
17. juli 2020
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive virksomhed omfattende almindeligt samt specialiseret dyrlægearbejde, osteopatik, kiropraktik, massage, fysioterapi, genoptræning og lignende behandling af dyr.
Salg af medicin, tilskud, foder og lignende, salg af terapeutiske hjælpemidler, som LED lys, magneter, laser og lignende, blandt andet i form af måtter, underlag, dækkener og lignende samt salg af tilbehør, udstyr, legetøj og lignende til dyr.
Salg af smykker lavet af dyrehår og lignende, rideudstyr til hest og rytter og lignende.
Salg af hvalpe.
Afholdelse af diverse kurser og uddannelse om træning af dyr, om sundhed, biomekanik, sygdomme, anatomi og lignende.
Address
Caroline Amalie Vej 137B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1.663 | 1.477 | 1.494 | 992 |
| Staff expenses | -919 | -1.338 | -1.409 | -944 |
| EBITDA | 482 | -17 | -103 | 48 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 482 | -17 | -103 | 48 |
| Net financials | -6 | -7 | 1 | 1 |
| Profit before tax | 476 | -24 | -102 | 49 |
| Tax | 111 | -5 | -23 | 11 |
| Net profit | 366 | -19 | -78 | 38 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 622 | 469 | 393 | 342 |
| Equity | 406 | 330 | 192 | 169 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 217 | 140 | 201 | 173 |
| Total debt | 217 | 140 | 201 | 173 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20212024
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
20212024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20212024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20212024
Asset turnover
2.90×
This company
1.12×
Market median
+159% vs market
20212024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-17 – 2021-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rebalancevet ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|